HUTCHMED (China) (HCM) Common Equity (2014 - 2025)

HUTCHMED (China)'s (HCM) quarterly Common Equity came in at $159.2 million in Q4 2025, up 62.83% year-on-year from $97.8 million in Q4 2024, and down 87.05% on a QoQ basis from $1.2 billion in Q2 2025.

HUTCHMED (China) (HCM) Common Equity (2014 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 12 years of Common Equity data on file, last reported at $159.2 million in Q4 2025.

  • On a quarterly basis, Common Equity rose 62.83% year-over-year to $159.2 million in Q4 2025; TTM through Dec 2025 was $159.2 million, a 62.83% increase from a year earlier, with the FY2025 full-year figure at $159.2 million, up 63.43% from the prior year.
  • Common Equity for Q4 2025 stood at $159.2 million, down from $1.2 billion in the prior quarter.
  • Over the last five years, Common Equity for HCM reached as high as $93.5 billion in Q4 2023 and fell as low as $78.0 million in Q4 2022.
  • Historically, Common Equity has averaged $9.0 billion across 5 years, with a median of $740.1 million in 2024.
  • Across the five-year window, Common Equity jumped 119722.09% in 2023 and slumped 99.9% in 2024, its largest moves.
  • Year by year, Common Equity stood at $126.7 million in 2021, then slumped by 38.41% to $78.0 million in 2022, then soared by 119722.09% to $93.5 billion in 2023, then slumped by 99.9% to $97.8 million in 2024, then jumped by 62.83% to $159.2 million in 2025.
  • Per Business Quant data, the three most recent Common Equity figures were $159.2 million in Q4 2025, $1.2 billion in Q2 2025, and $97.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.93 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 8.23 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 3.23 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 47.38 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.90 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 56.13 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 3.41 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.50 Bn
10 HUTCHMED (China) 241.90 Mn 243.61 Mn - 159.17 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 159.17 Mn
Jun 30, 2025 1.23 Bn
Dec 31, 2024 97.75 Mn
Jun 30, 2024 740.08 Mn
Dec 31, 2023 93.50 Bn
Jun 30, 2023 800.02 Mn
Dec 31, 2022 78.03 Mn
Jun 30, 2022 851.85 Mn
Dec 31, 2021 126.69 Mn
Jun 30, 2021 1.01 Bn
Mar 31, 2021 428.27 Mn
Dec 31, 2020 152.71 Mn
Jun 30, 2020 367.05 Mn
Sep 30, 2019 337.79 Mn
Jun 30, 2019 373.04 Mn
Mar 31, 2019 400.36 Mn
Dec 31, 2018 412.26 Mn
Jun 30, 2018 457.85 Mn
Dec 31, 2017 461.73 Mn
Jun 30, 2017 211.50 Mn